Many people are doing an end-run around their doctor's office, reaching out to potentially unreliable sources that promise to set them up with Wegovy, Zepbound and other weight-loss drugs.

More Tennessee companies are covering weight-loss injections in health care benefit plans. This could impact the state's high 37% obesity rate.

Four key factors can greatly impact how much weight people lose while taking GLP-1 drugs like Ozempic, Wegovy, Victoza, and Saxenda. Here's what to know.

Injectable prescription drugs that reduce appetite — like Ozempic, Saxenda and Mounjaro — have skyrocketed in popularity in recent years.

People taking the experimental drug amycretin were found to lose almost twice as much weight over a 12-week period as the average weight loss seen with semaglutide.

Weight loss drugs have gone viral. But despite their availability, most people who could benefit from treatments can't access them.

"Weight loss medications are not one size fits all and patients should always discuss options with a trusted medical professional," one expert told Newsweek.

Daily” pill is the latest product to capitalize on the weight loss drug craze. By Dani Blum There’s a long list of products that companies and influencers claim can deliver quick and dramatic weight loss,

However, the research found that exercising helped preserve bone loss. Experts said that the findings may apply to other GLP-1s, such as semaglutide, the active ingredient in Ozempic. A rapid drop in weight can result in a loss of bone density,